These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3841378)

  • 21. Hypergastrinemia in hyperthyroidism.
    Seino Y; Matsukura S; Miyamoto Y; Goto Y; Taminato T; Imura H
    J Clin Endocrinol Metab; 1976 Oct; 43(4):852-5. PubMed ID: 989772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement of immunologic abnormalities associated with hyperthyroidism of Graves' disease during methimazole treatment.
    Murakami M; Koizumi Y; Aizawa T; Yamada T; Ishihara M; Hasegawa Y; Ogata H; Kamoi K; Kaneko K
    Horm Metab Res; 1988 Apr; 20(4):235-8. PubMed ID: 3397034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The peripheral metabolism of triiodothyronine in normal subjects and in patients with hyperthyroidism.
    Woeber KA; Sobel RJ; Ingbar SH; Sterling K
    J Clin Invest; 1970 Apr; 49(4):643-9. PubMed ID: 5467580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapy of Graves' disease with sodium ipodate is associated with a high recurrence rate of hyperthyroidism.
    Martino E; Balzano S; Bartalena L; Loviselli A; Sica V; Petrini L; Grasso L; Piga M; Braverman LE
    J Endocrinol Invest; 1991 Nov; 14(10):847-51. PubMed ID: 1687043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacokinetics of digoxin in hyperthyroidism. Effect of methimazole].
    Izbicka M; Gasińska T; Dec R
    Wiad Lek; 2010; 63(1):10-6. PubMed ID: 20701025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pharmacokinetics of methimazole after oral administration of carbimazole and methimazole, in hyperthyroid patients.
    Skellern GG; Knight BI; Low CK; Alexander WD; McLarty DG; Kalk WJ
    Br J Clin Pharmacol; 1980 Feb; 9(2):137-43. PubMed ID: 7356900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial.
    Leo M; Bartalena L; Rotondo Dottore G; Piantanida E; Premoli P; Ionni I; Di Cera M; Masiello E; Sassi L; Tanda ML; Latrofa F; Vitti P; Marcocci C; Marinò M
    J Endocrinol Invest; 2017 Mar; 40(3):281-287. PubMed ID: 27734319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triiodothyronine toxicosis developing during antithyroid drug therapy for hyperthyroidism.
    Hollander CS; Shenkman L; Mitsuma T; Asper SP
    Johns Hopkins Med J; 1972 Aug; 131(2):184-8. PubMed ID: 5068365
    [No Abstract]   [Full Text] [Related]  

  • 29. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy.
    Antonelli A; Fallahi P; Rotondi M; Ferrari SM; Serio M; Miccoli P
    Br J Surg; 2006 Oct; 93(10):1226-31. PubMed ID: 16838393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low doses of cholestyramine in the treatment of hyperthyroidism.
    Kaykhaei MA; Shams M; Sadegholvad A; Dabbaghmanesh MH; Omrani GR
    Endocrine; 2008; 34(1-3):52-5. PubMed ID: 18946743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Graves' disease with delayed hyperthyroidism. Onset after several years of euthyroid ophthalmopathy, dermopathy, and high serum LATS.
    Chopra IJ; Solomon DH
    Ann Intern Med; 1970 Dec; 73(6):985-90. PubMed ID: 5538174
    [No Abstract]   [Full Text] [Related]  

  • 32. Significance of thyroid blood flow as a predictor of methimazole sensitivity in untreated hyperthyroid patients with Graves' disease.
    Nagasaki T; Inaba M; Kumeda Y; Fujiwara-Ueda M; Hiura Y; Nishizawa Y
    Biomed Pharmacother; 2007 Sep; 61(8):472-6. PubMed ID: 17420111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of hyperthyroid atrial fibrillation associated with Graves disease by prednisone].
    Wei H; Li M; Qiu M
    Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(12):810-2. PubMed ID: 12126525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic properties and bioavailability of methimazole.
    Jansson R; Lindström B; Dahlberg PA
    Clin Pharmacokinet; 1985; 10(5):443-50. PubMed ID: 4042519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism.
    Hashizume K; Ichikawa K; Sakurai A; Suzuki S; Takeda T; Kobayashi M; Miyamoto T; Arai M; Nagasawa T
    N Engl J Med; 1991 Apr; 324(14):947-53. PubMed ID: 1900575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
    Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K
    J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum thyroglobulin concentration as an indicator for assessing thyroid stimulation in patients with Graves' disease during antithyroid drug therapy.
    Aizawa T; Ishihara M; Koizumi Y; Hashizume K; Takasu N; Yamada T; Kobayashi I; Watanabe T; Shimizu Z
    Am J Med; 1990 Aug; 89(2):175-80. PubMed ID: 2166430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The influence of hyperthyroidism and glucocorticosteroid treatment on bone metabolism in patients with Graves' disease and ophthalmopathy].
    Kaźmierczyk-Puchalska A; Kulig G; Krzyzanowska-Swiniarska B; Pilarska K
    Endokrynol Pol; 2005; 56(3):259-64. PubMed ID: 16350719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum lipid levels in thyroid dysfunction with special reference to transient elevation during treatment in hyperthyroid Graves' disease.
    Nishitani H; Okamura K; Noguchi S; Inoue K; Morotomi Y; Fujishima M
    Horm Metab Res; 1990 Sep; 22(9):490-3. PubMed ID: 2258137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in drug metabolism in children with thyroid disorders.
    Saenger P; Rifkind AB; New MI
    J Clin Endocrinol Metab; 1976 Jan; 42(1):155-9. PubMed ID: 1249184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.